rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Announcements
 for Astrazeneca Pharma India Ltd.
14 Feb Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
12 Feb Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
12 Feb Announcement under Regulation 30 (LODR)-Newspaper Publication
08 Feb Outcome Of The Board Meeting Held On Monday, February 8, 2021
06 Feb Astrazeneca Pharma India Limited Receives Import And Market Permission In Form CT-20 (Subsequent New Drug Approval) From The Drugs Controller General Of India For Dapagliflozin Tablets 10Mg
05 Feb Announcement under Regulation 30 (LODR)-Newspaper Publication
03 Feb Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
29 Jan Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Monday, February 8, 2021
27 Jan Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
21 Jan Statement Of Investor Complaints For The Quarter Ended December 2020
View announcements for all companies
Next >

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips

ALL MONEYWIZ PAGES

rediff on the net© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback